DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Progress on the development of Class A GPCR-biased ligands
Class A G protein-coupled receptors (GPCRs) continue to garner interest for their
essential roles in cell signalling and their importance as drug targets. Although numer-
ous drugs in the clinic target these receptors, over 60% GPCRs remain unexploited.
Moreover, the adverse effects triggered by the available unbiased GPCR modulators,
limit their use and therapeutic value. In this context, the elucidation of biased signal-
ling has opened up new pharmacological avenues holding promise for safer therapeu-
tics. Functionally selective ligands favour receptor conformations facilitating the
recruitment of specific effectors and the modulation of the associated pathways. This
review surveys the current drug discovery landscape of GPCR-biased modulators
with a focus on recent advances. Understanding the biological effects of this prefer-
ential coupling is at different stages depending on the Class A GPCR family. There-
fore, with a focus on individual GPCR families, we present a compilation of the
functionally selective modulators reported over the past few years. In doing so, we
dissect their therapeutic relevance, molecular determinants and potential clinical
applications., National Office of Research, Development and
Innovation, Grant/Award Number: RRF-
2.3.1-21-2022-00015; Ministerio de Ciencia e
Innovación, Grant/Award Numbers:
FJC2021-047571-I, PID2020-118511RB-I00,
PID2021-124010OB-100,
PID2021-126600OB-I00,
PID2021-127833OB-I00, PID2022-
139197OA-I00; Cancerfonden, Grant/Award
Number: 20 0264; National Institutes of
Health, Grant/Award Number: R01
DA0455698; German Research Foundation,
Grant/Award Numbers: 470002134, GRK
2158; Swedish Society for Medical Research,
Grant/Award Number: PG-22-0379-H-01;
Hungarian Academy of Sciences, Grant/Award
Number: NAP 3.0; Consellería de Cultura,
Educación e Ordenación Universitaria of the
Galician Government, Grant/Award Number:
ED431B 2020/43; Centro Singular de
Investigación de Galicia Accreditation 2019–
2022, Grant/Award Number: ED431G 2019/03; MCIN/
AEI/10.13039/501100011033/FEDER, UE,
Grant/Award Number: FJC2021-047571-I;
Karolinska Institutet, the Swedish Cancer Society, Grant/Award Number: 20 0264;
Swedish Research Council, Grant/Award
Number: 2022-01398; Czech Academy of
Sciences, Grant/Award Number: 67985823;
Grant Agency of Czech Republic, Grant/Award
Number: 23-04670S; Juan de la Cierva
Incorporación Programme, Grant/Award
Number: IJC 2019-042182-I; The Pew
Charitable Trusts; COST (European
Cooperation in Science and Technology),
Grant/Award Number: CA18133, Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-118511RB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-124010OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-127833OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-139197OA-I00